Track the Molecular Partners Ltd share price and the full management transaction log of the company, a publicly traded company based in Switzerland. Shares are listed on CH CH, under the supervision of SIX SER. Operating in the Health Care sector, Molecular Partners Ltd has published 2 reports. Market capitalisation: €126.6m. The latest transaction was disclosed on 2 April 2024 (Sale). Among the most active insiders: Anonymous (Executive member of the board of directors / member of senior management). The full history is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations